Dodgers identify Rays’ James Shields as “No. 1 target”

16 Comments

According to Mark Saxon of ESPN Los Angeles the Dodgers are looking to add another veteran starting pitcher with Chad Billingsley and Ted Lilly both question marks health-wise, and their “No. 1 target” is Rays right-hander James Shields.

Tampa Bay picked up Shields’ option for 2013, because at $10.25 million it’s a no-brainer, and he’s also under team control for 2014 via $12 million option.

Given their young pitching depth and payroll limitations it wouldn’t be surprising if the Rays are willing to take calls on Shields, but it would be surprising if they’re willing to deal him without getting a ton in return. During the past two seasons Shields has logged 477 innings with a 3.15 ERA and 448/123 K/BB ratio.

Astros’ Jonathan Singleton, Dean Deetz suspended for failing drug tests

Stacy Revere/Getty Images
Leave a comment

MLB.com’s Brian McTaggart reports that Astros first baseman Jonathan Singleton has been suspended 100 games after testing positive for a drug of abuse for a third time. Minor league pitcher Dean Deetz has been suspended 80 games after testing positive for Dehydroclormethyltestosterone.

Singleton, 26, has had issues with marijuana in the past and opened up about his addiction several years ago. He said, “At this point it’s pretty evident to me that I’m a drug addict. I don’t openly tell everyone that, but it’s pretty apparent to myself.” He added, “I know that I enjoy smoking weed, I enjoy being high and I can’t block that out of my mind that I enjoy that. So I have to work against that.”

Singleton hasn’t played in the majors since 2015. Last season, after going all the way back to Double-A Corpus Christi, he hit .205/.376/.397 with 18 home runs and 62 RBI in 500 plate appearances.

Deetz, 24, was selected by the Astros in the 11th round of the 2014 draft. Between Corpus Christi and Triple-A Fresno last season, the right-hander posted a 4.25 ERA with a 97/50 K/BB ratio in 84 2/3 innings of work. He denies knowingly using a PED, per ESPN’s Keith Law.